Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon add-on therapy for Tourette's syndrome
jRCTs021190012Completed
- Sponsor
- Akita University Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ramelteon in Tourette syndrome (TS), sponsored by Akita University Hospital. Primary endpoint: Yale Global Tic Severity Scale at 8 weeks. Started Nov 2019; status: completed.
02
Drugs
ramelteon
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on jRCTs021190012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021190012.